PUBLISHER: KBV Research | PRODUCT CODE: 1397704
PUBLISHER: KBV Research | PRODUCT CODE: 1397704
North America Legionella Testing Market Size, Share & Industry Trends Analysis Report By Type, By End-User (Clinical Laboratories, Hospitals & Clinics, and Others), By Country and Growth Forecast, 2023 - 2030
The North America Legionella Testing Market would witness market growth of 8.9% CAGR during the forecast period (2023-2030).
Legionellosis is a severe respiratory disorder caused by Legionella. The health disorder is a serious concern and requires hospitalization and intensive care. The escalating incidence of Legionellosis has correspondingly heightened the need for disease management strategies. Effective disease management necessitates the implementation of appropriate diagnostic and therapeutic approaches. Thus, increasing demand for rapidly advanced diagnostic techniques is likely to drive the growth of the market.
The testing involves examining and evaluating Legionella bacteria in diverse environments, including cooling towers, water systems, and other areas where the growth of Legionella bacteria could potentially endanger human health. Water treatment companies, testing laboratories, healthcare facilities, and government organizations tasked with overseeing and regulating Legionella control measures are all participants in the market. The testing is an essential component in the prevention and management of Legionnaires' disease as it permits the identification and remediation of Legionella bacteria across diverse environments, thereby ensuring the protection of public health.
In the 2021 Census, the number of Canadians aged eighty-five and older surpassed 861,000, a rise of more than twofold compared to the 2001 Census, according to Statistics Canada. Over the age of 85, the population has increased by 12% since 2016, making it one of the age groups experiencing the most rapid development. At present, 2.3% of the population is aged 85. In the twenty-five years leading up to 2046, the elderly population could nearly triple to 2.5 million individuals. Thus, the growing elderly population of the region is impacting the market positively.
The US market dominated the North America Legionella Testing Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $149,723.8 Thousand by 2030. The Canada market is experiencing a CAGR of 11.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.4% during (2023 - 2030).
Based on Type, the market is segmented into Polymerase Chain Reaction (PCR), Culture Media, Urine Antigen Testing (UAT), Serology, and Direct Fluorescent Antibody (DFA) Test. Based on End-User, the market is segmented into Clinical Laboratories, Hospitals & Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include QuidelOrtho Corporation, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Becton Dickinson and Company, BioMerieux S.A., IDEXX Laboratories, Inc., Eurofins Scientific SE and Qiagen N.V
Scope of the Study
Market Segments covered in the Report:
By Type
- Polymerase Chain Reaction (PCR)
- Culture Media
- Urine Antigen Testing (UAT)
- Serology
- Direct Fluorescent Antibody (DFA) Test
By End-User
- Clinical Laboratories
- Hospitals & Clinics
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- QuidelOrtho Corporation
- Abbott Laboratories
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Becton Dickinson and Company
- BioMerieux S.A.
- IDEXX Laboratories, Inc.
- Eurofins Scientific SE
- Qiagen N.V
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Legionella Testing Market, by Type
- 1.4.2 North America Legionella Testing Market, by End-User
- 1.4.3 North America Legionella Testing Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. North America Legionella Testing Market, by Type
- 4.1 North America Polymerase Chain Reaction (PCR) Market, by Country
- 4.2 North America Culture Media Market, by Country
- 4.3 North America Urine Antigen Testing (UAT) Market, by Country
- 4.4 North America Serology Market, by Country
- 4.5 North America Direct Fluorescent Antibody (DFA) Test Market, by Country
Chapter 5. North America Legionella Testing Market, by End-User
- 5.1 North America Clinical Laboratories Market, by Country
- 5.2 North America Hospitals & Clinics Market, by Country
- 5.3 North America Others Market, by Country
Chapter 6. North America Legionella Testing Market, by Country
- 6.1 US Legionella Testing Market
- 6.1.1 US Legionella Testing Market, by Type
- 6.1.2 US Legionella Testing Market, by End-User
- 6.2 Canada Legionella Testing Market
- 6.2.1 Canada Legionella Testing Market, by Type
- 6.2.2 Canada Legionella Testing Market, by End-User
- 6.3 Mexico Legionella Testing Market
- 6.3.1 Mexico Legionella Testing Market, by Type
- 6.3.2 Mexico Legionella Testing Market, by End-User
- 6.4 Rest of North America Legionella Testing Market
- 6.4.1 Rest of North America Legionella Testing Market, by Type
- 6.4.2 Rest of North America Legionella Testing Market, by End-User
Chapter 7. Company Profiles
- 7.1 QuidelOrtho Corporation
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expense
- 7.2 Abbott Laboratories
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 SWOT Analysis
- 7.3 Merck KGaA
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 SWOT Analysis
- 7.4 Thermo Fisher Scientific, Inc.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.4.5 SWOT Analysis
- 7.5 Bio-Rad laboratories, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expenses
- 7.5.5 SWOT Analysis
- 7.6 Becton, Dickinson, and Company
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.6.5 SWOT Analysis
- 7.7 BioMerieux S.A.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.7.5 SWOT Analysis
- 7.8 IDEXX Laboratories, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Acquisition and Mergers:
- 7.8.6 SWOT Analysis
- 7.9 Eurofins Scientific SE
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Regional Analysis
- 7.9.4 SWOT Analysis
- 7.10. Qiagen N.V.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expense
- 7.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Legionella Testing Market, 2019 - 2022, USD Thousand
- TABLE 2 North America Legionella Testing Market, 2023 - 2030, USD Thousand
- TABLE 3 North America Legionella Testing Market, by Type, 2019 - 2022, USD Thousand
- TABLE 4 North America Legionella Testing Market, by Type, 2023 - 2030, USD Thousand
- TABLE 5 North America Polymerase Chain Reaction (PCR) Market, by Country, 2019 - 2022, USD Thousand
- TABLE 6 North America Polymerase Chain Reaction (PCR) Market, by Country, 2023 - 2030, USD Thousand
- TABLE 7 North America Culture Media Market, by Country, 2019 - 2022, USD Thousand
- TABLE 8 North America Culture Media Market, by Country, 2023 - 2030, USD Thousand
- TABLE 9 North America Urine Antigen Testing (UAT) Market, by Country, 2019 - 2022, USD Thousand
- TABLE 10 North America Urine Antigen Testing (UAT) Market, by Country, 2023 - 2030, USD Thousand
- TABLE 11 North America Serology Market, by Country, 2019 - 2022, USD Thousand
- TABLE 12 North America Serology Market, by Country, 2023 - 2030, USD Thousand
- TABLE 13 North America Direct Fluorescent Antibody (DFA) Test Market, by Country, 2019 - 2022, USD Thousand
- TABLE 14 North America Direct Fluorescent Antibody (DFA) Test Market, by Country, 2023 - 2030, USD Thousand
- TABLE 15 North America Legionella Testing Market, by End-User, 2019 - 2022, USD Thousand
- TABLE 16 North America Legionella Testing Market, by End-User, 2023 - 2030, USD Thousand
- TABLE 17 North America Clinical Laboratories Market, by Country, 2019 - 2022, USD Thousand
- TABLE 18 North America Clinical Laboratories Market, by Country, 2023 - 2030, USD Thousand
- TABLE 19 North America Hospitals & Clinics Market, by Country, 2019 - 2022, USD Thousand
- TABLE 20 North America Hospitals & Clinics Market, by Country, 2023 - 2030, USD Thousand
- TABLE 21 North America Others Market, by Country, 2019 - 2022, USD Thousand
- TABLE 22 North America Others Market, by Country, 2023 - 2030, USD Thousand
- TABLE 23 North America Legionella Testing Market, by Country, 2019 - 2022, USD Thousand
- TABLE 24 North America Legionella Testing Market, by Country, 2023 - 2030, USD Thousand
- TABLE 25 US Legionella Testing Market, 2019 - 2022, USD Thousand
- TABLE 26 US Legionella Testing Market, 2023 - 2030, USD Thousand
- TABLE 27 US Legionella Testing Market, by Type, 2019 - 2022, USD Thousand
- TABLE 28 US Legionella Testing Market, by Type, 2023 - 2030, USD Thousand
- TABLE 29 US Legionella Testing Market, by End-User, 2019 - 2022, USD Thousand
- TABLE 30 US Legionella Testing Market, by End-User, 2023 - 2030, USD Thousand
- TABLE 31 Canada Legionella Testing Market, 2019 - 2022, USD Thousand
- TABLE 32 Canada Legionella Testing Market, 2023 - 2030, USD Thousand
- TABLE 33 Canada Legionella Testing Market, by Type, 2019 - 2022, USD Thousand
- TABLE 34 Canada Legionella Testing Market, by Type, 2023 - 2030, USD Thousand
- TABLE 35 Canada Legionella Testing Market, by End-User, 2019 - 2022, USD Thousand
- TABLE 36 Canada Legionella Testing Market, by End-User, 2023 - 2030, USD Thousand
- TABLE 37 Mexico Legionella Testing Market, 2019 - 2022, USD Thousand
- TABLE 38 Mexico Legionella Testing Market, 2023 - 2030, USD Thousand
- TABLE 39 Mexico Legionella Testing Market, by Type, 2019 - 2022, USD Thousand
- TABLE 40 Mexico Legionella Testing Market, by Type, 2023 - 2030, USD Thousand
- TABLE 41 Mexico Legionella Testing Market, by End-User, 2019 - 2022, USD Thousand
- TABLE 42 Mexico Legionella Testing Market, by End-User, 2023 - 2030, USD Thousand
- TABLE 43 Rest of North America Legionella Testing Market, 2019 - 2022, USD Thousand
- TABLE 44 Rest of North America Legionella Testing Market, 2023 - 2030, USD Thousand
- TABLE 45 Rest of North America Legionella Testing Market, by Type, 2019 - 2022, USD Thousand
- TABLE 46 Rest of North America Legionella Testing Market, by Type, 2023 - 2030, USD Thousand
- TABLE 47 Rest of North America Legionella Testing Market, by End-User, 2019 - 2022, USD Thousand
- TABLE 48 Rest of North America Legionella Testing Market, by End-User, 2023 - 2030, USD Thousand
- TABLE 49 key information - QuidelOrtho Corporation
- TABLE 50 Key Information - Abbott Laboratories
- TABLE 51 key Information - Merck KGaA
- TABLE 52 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 53 Key Information - Bio-Rad Laboratories, Inc.
- TABLE 54 Key Information - Becton, Dickinson and Company
- TABLE 55 Key information - BioMerieux S.A.
- TABLE 56 Key Information - IDEXX Laboratories, Inc.
- TABLE 57 Key Information - Eurofins Scientific SE
- TABLE 58 Key Information - Qiagen N.V.
